PGx News

  • Fri, October 07, 2022 1:08 PM | Matt Riley (Administrator)

    We are happy to announce that Sara Van Driest, M.D., Ph.D. was selected by the National Institutes of Health’s All of Us Research Program to serve as the program’s first director of pediatrics.

    In this position, she will help set the foundation for how people under the age of 18 can participate in this landmark precision medicine effort.

    Dr. Van Driest is a PGRN member and the Secretary of Council. Her research has focused on improving the dosing and understanding the effects of commonly used medications, including antibiotics, analgesics, and sedatives in children. Among her many roles, she serves on the steering committee for the Clinical Pharmacogenetics Implementation Consortium and on the scientific advisory boards for PharmVar, a central repository for pharmacogenomic variation, and PharmCAT, a freely available pharmacogenomics clinical annotation tool.

  • Fri, September 30, 2022 9:00 AM | Matt Riley (Administrator)

    Dear PGRN members,

    Please join me in congratulating the following colleagues on receiving two prestigious awards from the American Society of Clinical Pharmacology and Therapeutics:

    Dr. Julie Johnson: ASCPT Mentor Award

    Dr. Jasmine Luzum: Leon I. Goldberg Early Investigator Award

    They are a point of pride for PGRN, and we look forward to their continuing success in pharmacogenomics and clinical pharmacology broadly.

    Best regards,

    Jun J. Yang

    President, PGRN

    Endowed Chair in Pharmacogenomics
    St. Jude Children's Research Hospital

  • Tue, January 11, 2022 10:50 AM | Matt Riley (Administrator)

    PGRN founding member Aniwaa Owusu Obeng, PharmD, is currently leading a PGx CME series hosted by the Mount Sinai Medical System, titled "The Clinician's Guide to Personalized Theraputics." Live zoom sessions started in late 2021 and will continue through September of 2022.

    PGRN members can find more information or register using the links below.

    More Details

    Register Now 

  • Fri, October 01, 2021 6:31 PM | Anonymous

    The mission of the PGRN Research Collaborative Grant is to foster collaboration among PGRN members to advance the science of pharmacogenomics as it relates to all aspects of precision medicine. Grants up to $20,000 will be awarded on a competitive basis to PGRN members who enter into collaborative arrangements, including with other academic researchers or industry partners. Proposals that include international collaboration and participants from diverse and understudied populations will be prioritized.

    For more information

  • Thu, September 30, 2021 12:14 PM | Anonymous

    ASCPT announced the 2022 ASCPT Award recipients who will be formally recognized during the 2022 virtual Annual Meeting. The ASCPT Awards have a rich history of recognizing excellence in the fields of clinical pharmacology and translational science. The 2022 recipients demonstrate devotion that drives innovation and achievement for the benefit of patients and society.

    We are proud to announce that two PGRN members will be receiving prestigious ASCPT Awards. Please take a moment to congratulate them for their achievements.

    Rawls-Palmer Progress in Medicine Award
    Deanna Kroetz, PhD, University of California San Francisco

    ASCPT Mentor Award
    Hendrik Jan Guchelaar, PharmD, PhD, Leiden University

  • Tue, July 27, 2021 3:17 PM | Anonymous

    On behalf of Matthias Schwab and myself, I am writing to cordially invite you to submit your work to Pharmacogenetics and Genomics. Established in 1991, the Journal is devoted to disseminating research discoveries related to pharmacogenomics and precision medicine. We strive to rapidly evaluate and publish high-quality work elucidating genetic determinants of drug response, ranging from genomic discovery to mechanistic studies, pre-clinical modeling, and clinical implementation.  

    As we celebrate the 30th Anniversary of the Journal this year and with the guidance of our editorial board ( board.aspx), we are committed to becoming the flagship publication platform in the field of pharmacogenomics. For this reason, we particularly value the impact of PGRN and sincerely call on PGRN members to consider Pharmacogenetics and Genomics for your next manuscript ( We also welcome volunteer reviewers; please email our editorial coordinator, Prachi Deshpande ( if you are interested. 

    Share your work and shape the future of pharmacogenomics!

    Jun J. Yang PhD and Matthias Schwab MD

    Chief Editors

  • Sun, May 16, 2021 2:59 PM | Anonymous

    Pharmacogenetic Testing in Healthy Individuals
    Due: Oct 10, 2021


  • Sun, May 16, 2021 2:55 PM | Anonymous

    Pharmacogenetics of Treating Anxiety & Depression

    Due Date: March 31, 2022

  • Mon, April 19, 2021 12:24 PM | Anonymous

    Initiative to Maximize Research Education in Genomics:  Diversity Action Plan (R25)

  • Mon, April 19, 2021 12:23 PM | Anonymous

    Advancing Genomic Medicine Research (R21 Clinical Trial Optional) (RFA-HG-20-037)

Copyright © 2020 the Pharmacogenomics Global Research Network. All Rights Reserved.

PGRN is a 501(c)3 Non-Profit Association

Follow PGRN
on Social Media

Become a Member

PGRN logo
Membership dues are vital to continue the mission and work of the PGRN. Join your colleagues today and suport the work of PGRN. 
Powered by Wild Apricot Membership Software